secwatch / observer
8-K filed September 7, 2022, 7:59 PM ET ticker CADL CIK 0001841387
leadership confidence high sentiment neutral materiality 0.60

Candel Therapeutics names new CFO and CMO; CFO Canepa resigns effective Sept 21

Candel Therapeutics, Inc.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Canepa

Chief Financial Officer
CADL · Candel Therapeutics, Inc.
Effective
2022-09-21
Successor
Jason Amello
Filed
September 7, 2022, 7:59 PM ET
On September 6, 2022, Candel Therapeutics, Inc. (the “Company”) accepted the resignation of John Canepa as the Company’s Chief Financial Officer, effective September 21, 2022.
Appointed

Jason Amello

Chief Financial Officer
CADL · Candel Therapeutics, Inc.
Effective
2022-09-21
Filed
September 7, 2022, 7:59 PM ET
Jason Amello as the Company’s Chief Financial Officer, effective September 21, 2022.
Appointed

Garrett Nichols

Chief Medical Officer
CADL · Candel Therapeutics, Inc.
Effective
2022-09-12
Filed
September 7, 2022, 7:59 PM ET
appointed Garrett Nichols. M.D., M.S., as the Company’s Chief Medical Officer, effective September 12, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Canepa resigned as Chief Financial Officer at Candel Therapeutics, Inc..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On September 6, 2022, Candel Therapeutics, Inc. (the “Company”) accepted the resignation of John Canepa as the Company’s Chief Financial Officer, effective September 21, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Amello was appointed as Chief Financial Officer at Candel Therapeutics, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Jason Amello as the Company’s Chief Financial Officer, effective September 21, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Garrett Nichols was appointed as Chief Medical Officer at Candel Therapeutics, Inc..

Action
appointed
Role
Chief Medical Officer
Exact text from the filing
appointed Garrett Nichols. M.D., M.S., as the Company’s Chief Medical Officer, effective September 12, 2022
View on SEC.gov

Candel Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-22-239512
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.